Xufu Wei

1.2k total citations
33 papers, 890 citations indexed

About

Xufu Wei is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Xufu Wei has authored 33 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 15 papers in Cancer Research and 7 papers in Surgery. Recurrent topics in Xufu Wei's work include MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (10 papers) and Circular RNAs in diseases (7 papers). Xufu Wei is often cited by papers focused on MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (10 papers) and Circular RNAs in diseases (7 papers). Xufu Wei collaborates with scholars based in China, United States and Sweden. Xufu Wei's co-authors include Zhongjun Wu, Rui Liu, Chengyong Tang, Cui Tan, Tingxiu Xiang, Guosheng Ren, Daofeng Zheng, Junliang Pu, Tong Mou and Zhen Guo and has published in prestigious journals such as Hepatology, Life Sciences and Cell Reports.

In The Last Decade

Xufu Wei

33 papers receiving 882 citations

Peers

Countries citing papers authored by Xufu Wei

Since Specialization

Citations

This map shows the geographic impact of Xufu Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xufu Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xufu Wei more than expected).

Fields of papers citing papers by Xufu Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xufu Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xufu Wei. The network helps show where Xufu Wei may publish in the future.

Co-authorship network of co-authors of Xufu Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Xufu Wei. A scholar is included among the top collaborators of Xufu Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xufu Wei. Xufu Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploring tumor heterogeneity in colorectal liver metastases by imaging: Unsupervised machine learning of preoperative CT radiomics features for prognostic stratification 2024 ·European Journal of Radiology ·Qiang Wang, Henrik Nilsson, Keyang Xu, Xufu Wei, Danyu Chen, (unknown), Xiaojun Hu, Anrong Wang, (unknown)	8
2	Inhibition of SIRT7 promotes STAT1 activation and STAT1-dependent signaling in hepatocellular carcinoma 2023 ·Cellular Signalling ·Ling Dong, Xufu Wei, Le Yu, Yixin Li, Lixue Chen	1
3	Comparison of laparoscopic versus open radical antegrade modular pancreatosplenectomy for pancreatic cancer: A systematic review and meta-analysis 2022 ·International Journal of Surgery ·Wei Tang, (unknown), Yufei Zhao, Xufu Wei, (unknown), Qiao Wu, Chengyou Du, Jianguo Qiu	8
4	LncRNA RPPH1 acts as a molecular sponge for miR-122 to regulate Wnt1/β-catenin signaling in hepatocellular carcinoma 2022 ·International Journal of Medical Sciences ·Jian Zhou, (unknown), Wei-Feng Huang, Yuke Zhang, (unknown), Tong Mou, Zhongjun Wu, Xufu Wei	5
5	Endoscopic Endoluminal Radiofrequency Ablation and Single-Operator Peroral Cholangioscopy System (SpyGlass) in the Diagnosis and Treatment of Intraductal Papillary Neoplasm of the Bile Duct: A Case Report and Literature Review 2021 ·Frontiers in Medicine ·Wei Tang, Jianguo Qiu, Xufu Wei, (unknown), (unknown), Shaodong Wang, Chengyou Du, (unknown)	7
6	Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma 2021 ·Frontiers in Oncology ·Rui Liao, Lei Liu, Jian Zhou, Xufu Wei, (unknown)	17
7	Long noncoding TMPO antisense RNA 1 promotes hepatocellular carcinoma proliferation and epithelial-mesenchymal transition by targeting the microRNA-126-3p/LRP6/β-catenin axis 2021 ·Annals of Translational Medicine ·Wei-Feng Huang, (unknown), (unknown), Yuke Zhang, (unknown), Xufu Wei	10
8	miR-744-5p suppresses tumor proliferation and metastasis by targeting transforming growth factor-beta 1 (TGF-β1) in hepatocellular carcinoma (HCC) 2021 ·Journal of Gastrointestinal Oncology ·Wei-Feng Huang, (unknown), (unknown), Yuke Zhang, (unknown), Xufu Wei, Zhongjun Wu	12
9	LETM1 Knockdown Promotes Autophagy and Apoptosis Through AMP-Activated Protein Kinase Phosphorylation-Mediated Beclin-1/Bcl-2 Complex Dissociation in Hepatocellular Carcinoma 2021 ·Frontiers in Oncology ·Baoyong Zhou, Changhong Yang, (unknown), (unknown), Heng Xiao, Xufu Wei, Ning Jiang, Zhongjun Wu	10
10	Fisetin mitigates hepatic ischemia-reperfusion injury by regulating GSK3β/AMPK/NLRP3 inflammasome pathway 2021 ·Hepatobiliary & pancreatic diseases international ·Junliang Pu, Zuotian Huang, Yunhai Luo, Tong Mou, Tingting Li, (unknown), Xufu Wei, Zhongjun Wu	34
11	miR-4458 inhibits the epithelial–mesenchymal transition of hepatocellular carcinoma cells by suppressing the TGF-<bold><roman>β</roman></bold> signaling pathway via targeting TGFBR1 2020 ·Acta Biochimica et Biophysica Sinica ·Yuke Zhang, Kun Shi, Hang Liu, Wei Chen, Yunhai Luo, Xufu Wei, Zhongjun Wu	15
12	IL-37b suppresses epithelial mesenchymal transition in hepatocellular carcinoma by inhibiting IL-6/STAT3 signaling 2018 ·Hepatobiliary & pancreatic diseases international ·(unknown), Daofeng Zheng, Ai Shen, (unknown), Xufu Wei, Tong Mou, (unknown), Rui Liu	9
13	IL-34 Inhibits Acute Rejection of Rat Liver Transplantation by Inducing Kupffer Cell M2 Polarization 2018 ·Transplantation ·(unknown), (unknown), Chengyong Tang, Zhongtang Li, Daofeng Zheng, Xufu Wei, Zhongjun Wu	45
14	IL-37 induces autophagy in hepatocellular carcinoma cells by inhibiting the PI3K/AKT/mTOR pathway 2017 ·Molecular Immunology ·Tingting Li, Di Zhu, Tong Mou, Zhen Guo, Junliang Pu, Qingsong Chen, Xufu Wei, Zhongjun Wu	78
15	Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis 2017 ·World Journal of Surgical Oncology ·Tong Mou, Di Zhu, Xufu Wei, Tingting Li, Daofeng Zheng, Junliang Pu, Zhen Guo, Zhongjun Wu	42
16	HNF‑4α promotes multidrug resistance of gastric cancer cells through the modulation of cell apoptosis 2017 ·Oncology Letters ·Yubo Ma, Xufu Wei, Zhongjun Wu	15
17	Resveratrol preconditioning protects hepatocytes against hepatic ischemia reperfusion injury via Toll-like receptor 4/nuclear factor-κB signaling pathway in vitro and in vivo 2016 ·International Immunopharmacology ·(unknown), Zhen Guo, Junliang Pu, Daofeng Zheng, Xufu Wei, Rui Liu, Chengyong Tang, Zhongjun Wu	43
18	Everolimus in de novo liver transplant recipients: a systematic review 2015 ·Hepatobiliary & pancreatic diseases international ·Chengyong Tang, Ai Shen, Xufu Wei, Qingdong Li, Rui Liu, (unknown), Yongzhong Wu, Zhongjun Wu	16
19	Circulating microRNA-101 as a potential biomarker for hepatitis B virus-related hepatocellular carcinoma 2013 ·Oncology Letters ·Yu Fu, Xufu Wei, Chengyong Tang, Jianping Li, Rui Liu, Ai Shen, Zhongjun Wu	47
20	miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A 2012 ·Cellular Signalling ·Xufu Wei, Tingxiu Xiang, Guosheng Ren, Cui Tan, Rui Liu, Xiao Xu, Zhongjun Wu	128

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact